State Of Wisconsin Investment Board Kaleido Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.05 - $1.7 $1,095 - $37,230	-21,900 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.3 - $2.7 $19,110 - $39,690	-14,700 Reduced 40.16%	21,900 $36,000
Q4 2021 Feb 11, 2022	SELL	$2.39 - $6.02 $24,139 - $60,801	-10,100 Reduced 21.63%	36,600 $87,000
Q3 2021 Nov 12, 2021	BUY	$5.36 - $7.99 $26,264 - $39,151	4,900 Added 11.72%	46,700 $255,000
Q2 2021 Aug 12, 2021	BUY	$5.82 - $8.72 $10,476 - $15,696	1,800 Added 4.5%	41,800 $311,000
Q1 2021 May 17, 2021	BUY	$7.2 - $16.82 $169,920 - $396,952	23,600 Added 143.9%	40,000 $324,000
Q4 2020 Feb 03, 2021	BUY	$5.77 - $11.33 $94,628 - $185,812	16,400 New	16,400 $149,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.